text
"['\n1. 요약재무정보\n가. 연결 재무정보\n1) 요약재무정보(연결)\xa0\n(단위 : 원 )\n구 분\n제65기 1분기\n제64기\n제63기\n[유동자산]\n30,376,397,991\n28,588,864,538\n23,933,161,412\nㆍ당좌자산\n23,023,093,683\n22,661,279,742\n15,830,750,836\nㆍ재고자산\n7,353,304,308\n5,927,584,796\n8,102,410,576\n[비유동자산]\n41,567,275,990\n42,458,018,123\n52,209,349,714\nㆍ투자자산\n7,453,976,934\n7,573,921,535\n4,808,645,719\nㆍ유형자산\n28,606,453,244\n29,399,326,805\n37,192,300,892\nㆍ무형자산\n471,764,393\n474,531,521\n2,208,933,367\nㆍ기타비유동자산\n5,035,081,419\n5,010,238,262\n7,999,469,736\n자산총계\n71,943,673,981\n71,046,882,661\n76,142,511,126\n[유동부채]\n11,065,997,847\n13,695,602,065\n13,032,311,572\n[비유동부채]\n8,543,371,437\n7,742,853,098\n9,847,745,051\n부채총계\n19,609,369,284\n21,438,455,163\n22,880,056,623\n[지배기업의 소유주에게 귀속되는 자본]\n52,334,304,697\n49,608,155,461\n53,262,300,152\nㆍ자본금\n59,291,502,500\n59,286,024,500\n50,899,498,000\nㆍ연결자본잉여금\n8,790,714,675\n9,514,139,231\n8,888,909,782\nㆍ연결기타자본항목\n184,374,591\n(524,477,868)\n261,152,333\nㆍ연결이익잉여금\n(15,932,287,069)\n(18,667,530,402)\n(6,787,259,963)\n[비지배지분]\n-\n272,037\n154,351\n자본총계\n52,334,304,697\n49,608,427,498\n53,262,454,503\n종속·관계·공동기업투자주식의 평가방법\n지분법\n지분법\n지분법\n2021년4월부터2021년6월까지\n2020년4월부터2021년3월까지\n2019년4월부터2020년3월까지\n매출액\n13,500,220,620\n52,020,405,167\n37,214,177,862\n영업이익(손실)\n657,725,816\n2,308,773,750\n(12,361,005,153)\n연결당기순이익(손실)\n2,690,568,632\n(15,274,852,893)\n(12,759,326,319)\n지배회사지분 순이익(손실)\n2,690,568,632\n(15,274,984,906)\n(11,996,066,386)\n보통주 기본주당순이익(손실)\n23\n(135)\n(116)\n보통주 희석주당순이익(손실)\n23\n(135)\n(116)\n연결에 포함된 회사수\xa0\xa0 (단위 : 개)\n1\n2\n2\n※ 한국채택국제회계기준 작성기준에 따라 작성되었습니다.\xa0\xa0\n2) 재무제표 재작성- 해당 없음 -\n3) 당기에 신규로 연결재무제표에 포함된 종속기업이나 당기 중 연결재무제표의 작성대상에서 제외된 종속기업은 다음과 같습니다.\xa0 \xa0\n회계기준\n제65기 1분기\n제64기\n제63기\n한국채택국제회계기준(K-IFRS)적용 시\n1) Orient Bioresource Center Inc\n1) ORIENT SCIENCE & HEALTHCARE, INC.2) Orient Bioresource Center Inc\n1) ORIENT SCIENCE & HEALTHCARE, INC.2) Orient Bioresource Center Inc\n(주1)\n연결실체의 종속회사인 Orient Bio-Resource Center(OBRC:합병법인)와 ORIENT SCIENCE & HEALTHCARE, INC(OSH:피합병법인)는 2021년 4월 23일 합병을 실시하였으며 OSH는 소멸하였습니다.\xa0\n4) 연결재무제표 작성 기준- 자세한 사항은 \'3. 연결재무제표 주석\'을 참조 바랍니다.\xa0\n나. 별도 재무정보\n1) 요약 재무정보(별도)\xa0\n(단위 : 원 )\n구 분\n제65기 1분기\n제64기\n제63기\n[유동자산]\n23,386,424,460\n22,744,621,414\xa0\n22,105,987,658\nㆍ당좌자산\n18,889,783,313\n17,634,949,147\xa0\n16,904,087,349\xa0\nㆍ재고자산\n3,502,433,866\n3,473,235,625\xa0\n3,629,453,520\xa0\nㆍ기타유동자산\n994,207,281\n1,636,436,642\xa0\n1,572,446,789\xa0\n[비유동자산]\n39,440,085,194\n40,212,480,419\xa0\n48,213,404,324\xa0\nㆍ투자자산\n14,989,141,960\n15,112,667,456\xa0\n11,909,167,950\xa0\nㆍ유형자산\n18,944,097,422\n19,615,043,180\xa0\n26,095,833,271\xa0\nㆍ무형자산\n471,764,393\n474,531,521\xa0\n2,208,933,367\xa0\nㆍ기타비유동자산\n5,035,081,419\n5,010,238,262\xa0\n7,999,469,736\xa0\n자산총계\n62,826,509,654\n62,957,101,833\xa0\n70,319,391,982\xa0\n[유동부채]\n10,412,241,870\n12,933,023,628\xa0\n10,516,224,051\xa0\n[비유동부채]\n8,543,371,437\n7,742,853,098\xa0\n9,847,745,051\xa0\n부채총계\n18,955,613,307\n20,675,876,726\xa0\n20,363,969,102\xa0\n[자본금]\n59,291,502,500\xa0\n59,286,024,500\xa0\n50,899,498,000\xa0\n[자본잉여금]\n3,869,095,656\xa0\n3,852,548,001\xa0\n3,227,318,552\xa0\n[기타자본항목]\n164,052,647\xa0\n164,052,647\xa0\n173,053,395\xa0\n[이익잉여금]\n(19,453,754,456)\n(21,021,400,041)\n(4,344,447,067)\n자본총계\n43,870,896,347\n42,281,225,107\xa0\n49,955,422,880\xa0\n종속·관계·공동기업투자주식의 평가방법\n지분법\n지분법\n지분법\n2021년4월부터2021년6월까지\n2020년4월부터2021년3월까지\n2019년4월부터2020년3월까지\n매출액\n6,629,868,843\n25,191,324,559\xa0\n23,026,306,643\xa0\n영업이익(손실)\n(505,114,317)\n(4,745,328,394)\n(9,712,026,775)\n당기순이익(손실)\n1,567,360,384\n(19,957,073,500)\n(20,626,424,531)\n보통주 기본주당순이익(손실)\n13\n(176)\n(196)\n보통주 희석주당순이익(손실)\n13\n(176)\n(196)\n※ 한국채택국제회계기준 작성기준에 따라 작성되었습니다.(별도 기준) 2) 재무정보 이용상의 유의점 (별도재무제표 기준)- 전기에 제출된 사업보고서의 첨부자료 ""5. 재무제표 주석""을 참조바랍니다.\xa0\n']"
